Cutler Group LP Lannett CO Inc Call Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 18, 2022	SELL	$1.56 - $2.93 $4,524 - $8,497	-2,900 Reduced 80.56%	700 $0
Q3 2021 Oct 26, 2021	SELL	$2.91 - $4.83 $18,333 - $30,429	-6,300 Reduced 63.64%	3,600 $0
Q2 2021 Jul 19, 2021	BUY	$4.17 - $5.74 $38,781 - $53,382	9,300 Added 1550.0%	9,900 $1,000
Q1 2020 May 07, 2020	SELL	$6.36 - $10.05 $1,272 - $2,010	-200 Reduced 25.0%	600 $1,000
Q3 2019 Oct 28, 2019	BUY	$5.58 - $14.47 $3,348 - $8,682	600 Added 300.0%	800 $2,000
Q1 2019 May 10, 2019	SELL	$5.35 - $9.82 $11,770 - $21,604	-2,200 Reduced 91.67%	200 $0
Q3 2018 Nov 07, 2018	SELL	$4.75 - $14.5 $14,250 - $43,500	-3,000 Reduced 55.56%	2,400 $1,000
Q1 2018 May 11, 2018	SELL	$14.7 - $24.95 $452,760 - $768,460	-30,800 Reduced 85.08%	5,400 $0
Q4 2017 Jan 17, 2018	SELL	$19.9 - $29.25 $312,430 - $459,225	-15,700 Reduced 30.25%	36,200 $61,000
Q3 2017 Oct 17, 2017	BUY	$15.1 - $19.25 $783,690 - $999,075	51,900	51,900 $52,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.